Suvretta Capital Management: Funding, Team & Investors | Startup Intros

Loading organizations...

Suvretta Capital Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 16, 2025	Veradermics	$150.0M Series C	Katarina Pance	abrdn, Infinitium, Invus, LifeSci Venture Partners, Longitude Capital, Marshall Wace, Surveyor Capital, Viking Global Investors
Sep 8, 2025	Avalyn Pharma	$100.0M Series D	SR One, Suvretta Capital Management	Norwest Venture Partners, Perceptive Advisors
Dec 11, 2024	Veradermics	$75.0M Series B	Amanda Birdsey-Benson	Vlad Coric, Connecticut Innovations, J.W. Childs Associates, Patrick Enright, Osage University Partners, PhiFund Ventures, Surveyor Capital
Jun 6, 2023	Zura Bio	$80.0M Other Equity	Deep Track Capital, Great Point Partners, Suvretta Capital Management	—
Dec 1, 2021	Freenome	$300.0M Series D	Ellen Hukkelhoven, Peter Kolchinsky	Anzu Partners, Ameena El-Bibany, Vasudev Bailey, Artis Ventures (AV), Asset Management Ventures, Bain Capital Life Sciences, Cofounders Capital, Merck Global Health Innovation Fund, Polaris Partners, RA Capital, Section 32, Anne Wojcicki, Timothy A. Springer, Andreessen Horowitz, ArrowMark Partners, BrightEdge Ventures, Byers Capital, Catalio Capital Management, Data Collective, Eventide Asset Management, Farallon Capital Management, Fidelity Management & Research Company, Google Ventures, HBM Healthcare Investments, Intermountain Ventures, Janus Henderson Investors, Kaiser Permanente, Logos Capital, Novartis, Polaris Partners, Pura Vida Investments, Ridgeback Capital Investments, Thomas Schinecker, Rock Springs Capital, Sands Capital, Soleus Capital, T. Rowe Price Associates
Jun 30, 2021	Turntide Technologies	$225.0M Other Equity	—	Breakthrough Energy Ventures, Yishai Lerner, Monashee Investment Management
Apr 1, 2021	Arcellx	$120.0M Series C	Samsara BioCapital, CAM Capital	Genoa Ventures, Adage, Asymmetry Ventures, CaaS Capital Management, Cambrian Biopharma, LG Tech, NEA, Novo Holdings, Sixty Degree Capital, SR One, Surveyor Capital, Takeda Ventures, Terra Magnum Capital Partners
Feb 15, 2021	HemoShear Therapeutics	$40.0M Series A	David Friedman	Adage Capital Management, Janus Henderson Investors
Feb 1, 2021	Pipeline Therapeutics	$80.0M Series C	—	Buff Gold Ventures, Versant Ventures, Casdin Capital, Franklin Templeton, Perceptive Advisors, Red Tree Venture Capital, Samsara BioCapital, Sectoral Asset Management
Jan 5, 2021	Terns Pharmaceuticals	$87.0M Series C	Elise Wang	Eli Lilly and Company, Lilly Asia Ventures, OrbiMed, Samsara BioCapital, Vivo Capital
Nov 9, 2020	Ambrx	$200.0M Other Equity	—	Adage Capital Management, BlackRock, Cormorant Asset Management, Fidelity Management & Research Company, HBM Healthcare Investments, Invus
Sep 28, 2020	BioShin	$60.0M Series A	David Wang	Cormorant Asset Management, HBM Healthcare Investments, Surveyor Capital